Adlai Nortye Announces First Patient Dosed in Phase Ia Clinical Trial of AN2025 and AN0025 in Combination with atezolizumab for Advanced Solid Tumors

Adlai Nortye Announces First Patient Dosed In Phase Ia Clinical Trial Of An2025 And An0025 In Combination With Atezolizumab For Advanced Solid Tumors

Facebook Comments

Leave a Reply

CommentLuv badge